Use of pat for active pharmaceutical ingredient crystallization process control

IFAC Proceedings Volumes (IFAC-PapersOnline)

Volumn 16, Issue , 2005, Pages 147-152

  Wu, Huiquan ^a   Hussain, Ajaz S ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Knowledge based control; On line control; Process control; Process models; Product quality; Systems concepts

Indexed keywords

CONTROLLED DRUG DELIVERY; KNOWLEDGE BASED SYSTEMS; THERMODYNAMICS;

ACTIVE PHARMACEUTICAL INGREDIENTS; CRYSTALLIZATION PROCESS; KNOWLEDGE-BASED CONTROL; ON-LINE CONTROLS; PHARMACEUTICAL CRYSTALLIZATIONS; PHARMACEUTICAL DRUGS; PROCESS MODEL; SCIENTIFIC KNOWLEDGE;

PROCESS CONTROL;

EID: 79960727124     PISSN: 14746670     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.3182/20050703-6-cz-1902.02228     Document Type: Conference Paper

References (38)

1. Alamdari, A. and Tabkhi, F., "Kinetics of hexamine crystallization in industrial scale", Chem. Eng. and Processing, 43, p. 803-810 (2004).
2. Chung, S. H., et al., "Optimal model-based experimental design in batch crystallization", Chemo. Int. Lab. Sys., 50, p. 83-90 (2000).
3. Damian, F., et al., "Thermal characterization of the antiviral drug UC-781 and stability of its glass", Thermochimica Acta, 366, p. 61-69 (2001).
4. Espitalier, F., et al., "Particle design Part A: Nucleation kinetics of ketoprofen", Chem. Eng. J., 68, p. 95-102 (1997).
5. Espitalier, F., et al., "Particle design Part B: batch quasi-emulsion process and mechanism of grain formation of ketoprofen", Chem. Eng. J., 68, p. 103-114 (1997).
6. Faure, A., et al., "Process control and scale-up of pharmaceutical wet granulation processes", Eur. J. Pharm. Biopharm., 52, p. 269-277 (2001).
7. FDA Guidance for Industry, PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. http://www.fda.gov/cder/guidance/6419fnl.pdf.
8. Févotte, G. and Klein, J. P., "Predictive temperature tracking for batch evaporative crystallizers: the partial state model reference approach", J. Pro. Control, 3(4), p. 225-232 (1993).
9. Févotte, G., "New perspectives for the on-line monitoring of pharmaceutical crystallization processes using in situ infrared spectroscopy", Int. J. of Pharm., 241, p. 263-278 (2002).
10. Fevotte, G., et al., "Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes", Int. J. Pharm., 273, p. 159-169 (2004).
11. Fujiwara, M., et al, "First-principles and direct design approaches for the control of pharmaceutical crystallization", J. Pro. Control, 15, p. 493- 504 (2005).
12. Gandhi, R. B., et al., "Pharmaceutical relationships of three solid state forms of stavudine", Int. J. Pharm., 201, p. 221-237 (2000).
13. Eric Garcia, E., et al., "Dissolution and phase transition of pharmaceutical compounds", J. Cry. Grow., 237-239, p. 2233-2239 (2002).
14. Georgieeva, P., et al., "Knowledged-based hybrid modeling of a batch crystallization when accounting for nucleation, growth and agglomeration phenomena", Chem. Eng. Sci., 58, p. 3699-3713 (2003).
15. Guan, X. and Pitchumani, "Modeling of spherulitic crystallization in thermoplastic towplacement process: heat transfer analysis", Comp. Sci. Tech., 64, p. 1123-1134 (2004).
16. Haidar, S. H., et al, "Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks, " Pharm. Res., 19 (1), p. 87-91 (2002).
17. Hornedo, N. R. and Murphy, D., "Significance of Controlling Crystallization Mechanisms and Kinetics in Pharmaceutical Systems", J. Pharm. Sci., 88 (7), p. 651-660 (1999).
18. Leane, M. M., et al, "The Use of Artificial Neural Networks for the Selection of the Most Appropriate Formulation and Processing Variables in Order to Predict the In Vitro Dissolution of Sustained Release Minitablets", AAPS PharmSciTech 2003; 4(2) Article 26.
19. Meadhra, R. O. and Rosmalen, G. M. V., "Scale-up of Ammonium Sulphate Crystallization in A DTB Crystallizer", Chem. Eng. Sci., 51, p. 3943-3950 (1996).
20. Miletic, I., et al., "An industrial perspective on implementing on-line applications of multivariate statistics", J. Pro. Control, 14, p. 821-836 (2004).
21. Murphy, D., et al., "Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and effect of lattice disorder", Int. J. of Pharm., 246, p. 121-134 (2002).
22. Monnier, O., et al., "Model identification of batch cooling crystallization through calorimetry and image analysis", Chem. Eng. Sci., 52, p. 1125-1139 (1997).
23. Norris, T., et al., "Determination of End-points for Polymorph Conversations of Crsyalline Organic Compounds Using On-line Nearinfrared Spectroscopy", The Analyst, 12, p. 549-552 (1997).
24. R. L. Parker, R. L., "Ultrasonic measurement of solid/liquid interface position during solidification and melting of metals", AIP Conf. Pro., Issue 84, p. 254-271 (1982).
25. Parker, R. L., et al., "Application of pulse-echo ultrasonics to locate the solid/liquid interface during solidification and melting of steel and other metals", J. Appl. Physics, 58(11), p. 4150-4164 (1985).
26. Peres, J. et al, "Knowledge based modular networks for process modeling and control", Comp. Chem. Eng., 25, p. 783-791 (2001).
27. F. Puel, F., et al., "Simulation and analysis of industrial crystallization processes through multidimensional population balance equations. Part 1: a resolution algorithm based on the method of classes", Chem. Eng. Sci., 58, p. 3715-3727 (2003).
28. Randolph, A. D. and Larson, M. A. Theory of Particulate Processes, 2nd ed., Academic Press, New York, NY (1988).
29. Seborg, D. E., et al., Process Dynamics and Control, John Wiley & Sons, New York, NY (1989).
30. Schmachtl, M., et al., "Crystallization process control during directional solidification in a high-temperature-gradient furnace by guided ultrasonic waves and real-time signal evaluation", Ultrasonics, 36, p. 291-295 (1998).
31. Starbuck, C., et al., "Process Optimization of a Complex Pharmaceutical Ploymorphic System via In Situ Raman Spectroscopy", Crystal Growth & Design, 2 (6), p. 515-522 (2002).
32. Stephenson, G. A., et al., "Characterization of the solid state: quantative issues", Adv. Drug Delivery Reviews, 48, p. 67-90 (2001).
33. Taday, P. F., et al., "Using Terahertz Pulse Spectroscopy to Study the Crystalline Structure of a Drug: A Case Study of the Ploymorphs of Rantidine Hydrochloride", Journal of Pharmaceutical Sciences, 92(4), p. 831-837 (2003).
34. Togkalidou, T., et al., "Experimental Design and Inferential Modeling in Pharmaceutical Crystallization", AIChE Journal, 47(1), p. 160-168 (2001).
35. Joachim Ulrich, J., and Strege, C., "Some aspects of the importance of metastable zone width and nucleation in industrial crystallizers", Journal of Crystal Growth, 237-239, p. 2130-2135 (2002).
36. Wang, F., et al., "An investigation of the solventmediated polymorphic transformation progesterone using in situ Raman spectroscopy", Org. Process Res. Dev., 4, p. 391-395 (2000).
37. Wynm E. J. W. and Hounslow, M. J., "Integral population balance equations for growth", Chemical Engineering Science, 52(5), p. 733-746 (1997).
38. Yu, L., et al., "Physical characterization of polymorphic drugs: an integrated characterization strategy", Pharm. Sci. & Tech. Today, 1(3), p. 118-127 (1998).